Details for Patent: 7,967,011
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 7,967,011 protect, and when does it expire?
Patent 7,967,011 protects SYMBICORT and is included in one NDA.
Protection for SYMBICORT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty-one patent family members in twenty-four countries.
Summary for Patent: 7,967,011
Title: | Inhalation device |
Abstract: | Actuator for an inhaler for delivering medicament by inhalation, having a mouthpiece for guiding medicament to the mouth of a user; and a removable protection cap for the mouthpiece. The cap is secured to the mouthpiece by a cap retaining member that engages a mating recess in the mouthpiece outer periphery. The cap includes at least one release button arranged to provide an elastic deformation of the cap inner periphery that disengages the cap retaining member from the recess. |
Inventor(s): | Hodson; Darren (Shropshire, GB), Rasmussen; Jorgen (Struer, DK) |
Assignee: | AstraZeneca AB (Sodertalje, SE) |
Application Number: | 11/346,558 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,967,011 |
Patent Claim Types: see list of patent claims | Delivery; |
Drugs Protected by US Patent 7,967,011
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-001 | Jul 21, 2006 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-002 | Jul 21, 2006 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,967,011
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Sweden | 9704185 | Nov 14, 1997 |
International Family Members for US Patent 7,967,011
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 1183699 | See Plans and Pricing | |||
Australia | 1266799 | See Plans and Pricing | |||
Australia | 728125 | See Plans and Pricing | |||
Australia | 750351 | See Plans and Pricing | |||
Brazil | 9814139 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |